3rd Quarter - Report

BURRELL INTERNATIONAL GROUP LLC for HOMOLOGY MEDICINES

Firm
Client
Income
$20,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

Drug pricing, gene therapy, and rare disease funding generally; Advancing Access to Precision Medicine; Newborn Screening Saves Lives Reauthorization Act; Genome Editing Threat Assessment Act; Medical Nutrition Equity Act; STAT Act and Rare Disease Legislation proposals

LobbyistCovered position, as disclosed
DEBORAH LYNN BURRELL —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details. Other amounts

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.